News Releases

Print This Page Bookmark this Page Email this Page

FzioMed Patent US 9,636,434, May 2,2017

May 19, 2017

COMPOSITIONS OF CARBOXYMETHYLCELLULOSE AND POLYETHYLENE OXIDE IONICALLY CROSS-LINKED USING POLYHYDROXYL ORGANIC ANIONS.

San Luis Obispo, California, May 2, 2017. FzioMed, which celebrates 21 years in business this year has received a new  patent, US 9,636,434. Methods for manufacturing ionically cross-linked compositions of carboxypolysaccharides, polyalkylene oxides,polyhydroxyl organic anions, optionally divalent cations and aqueous media are also provided.

“This patent greatly expands and strengthens our current patent portfolio and enables manufacturing flexibility as we enter new market segments”, said John Krelle, President and CEO of FzioMed.

“Our products for adhesion prevention and tissue lubrication are covered by multiple patents and include; Oxiplex® for reduction of pain and symptoms following spine surgery, Dynavisc® to reduce fibrosis following tendon and peripheral nerve surgery, Oxiplex/AP® for adhesion prevention after peritoneal and intrauterine surgery and Laresse®, a dermal filler for correction of facial lines and folds”.

About FzioMed, Inc.

FzioMed, Inc. is a privately held medical device company that develops, manufactures and markets absorbable surgical biomaterials based on its patented scientific technology. For more information, please visit www.fziomed.com

FzioMed®, Oxiplex®,Oxiplex/AP®, Laresse® and Dynavisc® are registered trademarks of FzioMed, Inc.


Back to NewsBack to News